ProfileGDS4718 / 206152_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 70% 73% 65% 73% 73% 64% 68% 72% 73% 70% 72% 69% 70% 69% 66% 72% 69% 67% 66% 77% 71% 69% 70% 69% 68% 67% 68% 64% 72% 70% 67% 64% 76% 71% 66% 64% 66% 71% 71% 62% 70% 68% 65% 63% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.8481170
GSM549102patient 115, normal, homogenized [OPG study]7.1178573
GSM549104patient 119, normal, homogenized [OPG study]6.5020765
GSM549108patient 138, normal, homogenized [OPG study]7.0579273
GSM549119patient 077, normal, homogenized [OPG study]7.0482973
GSM549133patient 032, cancer, homogenized [OPG study]6.4355164
GSM549139patient 042, cancer, homogenized [OPG study]6.7332768
GSM549099patient 107, normal, homogenized [OPG study]7.0236772
GSM549109patient 139, normal, homogenized [OPG study]7.1053773
GSM549110patient 046, normal, homogenized [OPG study]6.8169970
GSM549114patient 063, normal, homogenized [OPG study]7.0708672
GSM549122patient 082, normal, homogenized [OPG study]6.8140969
GSM549134patient 033, cancer, homogenized [OPG study]6.8923770
GSM549136patient 036, cancer, homogenized [OPG study]6.7794669
GSM549140patient 044, cancer, homogenized [OPG study]6.5331366
GSM549111patient 047, normal, homogenized [OPG study]7.0589372
GSM549113patient 057, normal, homogenized [OPG study]6.8396669
GSM549132patient 031, cancer, homogenized [OPG study]6.6393767
GSM549137patient 038, cancer, homogenized [OPG study]6.5450766
GSM549142patient 047, cancer, homogenized [OPG study]7.3534477
GSM549100patient 110, normal, homogenized [OPG study]6.8847171
GSM549107patient 135, normal, homogenized [OPG study]6.7564369
GSM549115patient 068, normal, homogenized [OPG study]6.8673370
GSM549116patient 072, normal, homogenized [OPG study]6.7942469
GSM549120patient 078, normal, homogenized [OPG study]6.7185868
GSM549131patient 030, cancer, homogenized [OPG study]6.6440267
GSM549118patient 074, normal, homogenized [OPG study]6.715268
GSM549129patient 027, cancer, homogenized [OPG study]6.4589864
GSM549123patient 088, normal, homogenized [OPG study]7.0805672
GSM549124patient 006, cancer, homogenized [OPG study]6.8679370
GSM549126patient 015, cancer, homogenized [OPG study]6.6566867
GSM549128patient 025, cancer, homogenized [OPG study]6.4101464
GSM549103patient 117, normal, homogenized [OPG study]7.3008376
GSM549117patient 073, normal, homogenized [OPG study]6.9001271
GSM549138patient 041, cancer, homogenized [OPG study]6.5729366
GSM549141patient 045, cancer, homogenized [OPG study]6.4209764
GSM549130patient 028, cancer, homogenized [OPG study]6.5537766
GSM549101patient 111, normal, homogenized [OPG study]6.9221771
GSM549105patient 128, normal, homogenized [OPG study]6.9632371
GSM549106patient 134, normal, homogenized [OPG study]6.2248762
GSM549112patient 048, normal, homogenized [OPG study]6.8517370
GSM549125patient 011, cancer, homogenized [OPG study]6.7176168
GSM549127patient 024, cancer, homogenized [OPG study]6.5815365
GSM549135patient 035, cancer, homogenized [OPG study]6.347663